Loading...

agilon health inc (NYSE:AGL)

21.63 USD -0.32 USD ( -1.46% )
Watchlist Manager
agilon health inc
NYSE:AGL
Watchlist

EV/EBITDA
Enterprise Value to EBITDA

The Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
=
Enterprise Value
/
EBITDA
Current EV/EBITDA
AGL
-21.2
Median EV/EBITDA
AGL
N/A
Industry EV/EBITDA
Health Care
10.6

EV/EBITDA History

Statistics
Enterprise Value to EBITDA

1 Year 3 Years 5 Years
Average -24.6 -8.6 -5.2
Median -25.4 N/A N/A
Min N/A N/A N/A
Max -15 -15 -15

History Chart
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-1 226.2
2-Years Forward
EV/EBITDA
86.6
3-Years Forward
EV/EBITDA
36.9

EV/EBITDA Across Competitors

AGL Competitors
agilon health inc Competitors

Relative Valuation Report

View full relative valuation report for agilon health inc, which takes into account all AGL`s valuation multiples.

See Also

Similar Stocks